Table 2 Cytoplasmic-Pin1 Staining and Clinicopathologic Characteristics of Melanoma Patients.

From: Cytoplasmic Pin1 expression is increased in human cutaneous melanoma and predicts poor prognosis

Variables

Cyto-Pin 1 Staining

Low, No. (%)

High, No. (%)

Total

Pa

Primary melanoma

Age, y

   ≤60

152 (85.9)

25 (14.1)

177

0.872

   >60

147 (86.5)

23 (13.5)

170

 

Sex

   Male

169 (86.7)

26 (13.3)

195

0.760

   Female

130 (85.5)

22 (14.5)

152

 

Tumor thickness, mm

   ≤1.0

104 (87.4)

15 (12.6)

119

0.855

   1.01–2.00

79 (84.9)

14 (15.1)

93

 

   2.01–4.00

51 (83.6)

10 (16.4)

61

 

>4.00

65 (87.8)

9 (12.2)

74

 

Ulceration

    Absent

243 (86.5)

38 (13.5)

281

0.730

   Present

56 (84.8)

10 (15.2)

66

 

Subtype

Lentigomaligna

69 (94.5)

4 (5.5)

73

0.231

   Superficial spreading

110 (84.0)

21 (16.0)

131

 

   Nodular

43 (82.7)

9 (17.3)

52

 

   Acrolentigous melanoma

9 (81.8)

2 (18.2)

11

 

   Unspecified

68 (85.0)

12 (15.0)

80

 

Siteb

   Sun-protected

212 (76.5)

39 (71.3)

251

0.137

   Sun-exposed

87 (23.5)

9 (28.7)

96

 

Metastatic melanoma

Age, y

   ≤59

82 (82.0)

18 (18.0)

100

0.753

   >59

73 (80.2)

18 (19.8)

91

 

Sex

   Male

109 (81.3)

25 (18.7)

134

0.916

   Female

46 (80.7)

11 (19.3)

57

 

AJCC stage

   I

168 (85.7)

28 (14.3)

196

0.408

   II

131 (86.8)

20 (13.2)

151

 

   III

65 (83.3)

13 (16.7)

78

 

   IV

90 (79.6)

23 (20.4)

113

 
  1. AJCC indicates American Joint Committee on Cancer.
  2. aChi - square test.
  3. bSun-protected sites: trunk, arm, leg, back, and feet; sun-exposed sites: head and neck.